Autolus Therapeutics's total assets for Q1 2025 were $746.34M, a decrease of -4.65% from the previous quarter. AUTL total liabilities were $375.23M for the fiscal quarter, a 5.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.